Johnathan Lancaster has joined Myriad Genetics as the vice president of Medical Affairs for Oncology, effective Feb. 9. He will provide medical and scientific leadership across the company's portfolio of molecular and companion diagnostic products and services for oncology. Lancaster will report to Lloyd Sanders, GM for the oncology business unit at Myriad Genetic Laboratories.
Lancaster has spent the past 12 years at Moffitt Cancer Center, where he's held several posts, including president of Moffitt Medical Group, deputy physician-in-chief and director of the Center for Women's Oncology, and chair of the department of women's oncology. Prior to Moffitt, he was medical director of the Gynecology Dysplasia Clinic at Duke University Medical Center.